Safety and efficacy of 0.02% and 0.01% atropine on controlling myopia progression: a 2-year clinical trial Post date November 15, 2022 ← The Association of Choroidal Thickening by Atropine with Treatment Effects for Myopia: Two-Year Clinical Trial of the LAMP Study → Cost of Myopia Correction: A Systematic Review
